Neudle.com: TNF inhibitor

Neurology Specific Literature Search

Differential
(Click to cross reference)

abdominal reflex, absent

abortion, spontaneous

acetylcholine receptor

acetylcholine receptor antibody

acoustic neurinoma

acquired immunodeficiency syndrome

advances in neurology

adverse drug reaction

Alzheimer's disease

Alzheimer's disease, early onset

Alzheimer's disease, treatment of

amblyopia, toxic

AMPA receptor antibodies

amyloid beta protein

amyloid beta protein antibodies

amyloid deposition

amyloid plaques

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

angiitis, granulomatous of CNS

angiotensin-converting enzyme

ankylosing spondylitis

anti GQ1b IgG antibody

anti JC virus antibodies

anti Yo antibody

anti-amyloid therapy

antineutrophil cytoplasmic autoantibodies

apolipoprotein E

apoliprotein E, plasma level

area postrema syndrome

arteritis, temporal

arteritis, temporal, recurrent

ataxia, cerebellar

ataxia, progressive

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune encephalopathy

autonomic dysfunction

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection, CNS

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

behavioral disorder, acute

Behcet's syndrome

biologic markers

bone marrow transplantation

brachial plexus injury

brachial plexus neuropathy

brain biopsy, false negative

brain biopsy, negative

brainstem, lesion of

Broca's aphasia

burning paresthesia

calcification, intracranial

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

cancer associated myopathy

candida albicans

carcinoma of breast

carcinoma of lung

carcinoma of ovary

cardiac surgery

cardiac surgery, neurologic complications with

cardiac transplantation

CAT scan, abdomen

CAT scan, abnormal

CAT scan, chest

CAT scan, contrast enhanced, subepend.

CAT scan, emission, abnormal

cauda equina, enhancement

cauda equina, lesion of

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellitis, autoimmune

cerebellum, disease of

cerebral arteries

cerebral cortex

cerebral edema, vasogenic

cerebral hypersensitivity, delayed

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS tumors

cerebrospinal fluid, cytology

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, secondary prevention

cerebrovascular disease

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

choreoathetosis

Clinical Pathologic Conference(C.P.C.)

cluster headache

collapsin response mediator protein 5 IgG

confusional state, acute

congenital malformation

congestive heart failure

contraindications

controversies in neurology

corneal dystrophy

corpus callosum, lesion of

cost effectiveness

cranial neuropathy

C-reactive protein, elevated

critical care unit

cyclophosphamide

cytomegalovirus infection

delay in diagnosis

dementia, autoimmune

dementia, rapidly progressive

dementia, reversible

dementia, treatment of

demyelinating disease

dentate nuclei, lesion of

dermatomyositis

developmental milestones, loss of

diabetes insipidus

diagnostic criteria

differential diagnosis

disability rating scale, neurological

disability, neurological

disease modifying agents

diurnal variation

DPPX, antibodies, encephalitis

drug induced neurologic disorders

drug withdrawal

dyskinesia, buccal lingual facial

dyskinesia, facial

efgartigimod alfa

electroencephalogram, abnormalities of

electron microscopy

emotional lability

encephalitis, acanthamoeba

encephalitis, amebic

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, viral

encephalopathy, anoxic

encephalopathy, delayed

epidemiology of neurology

episodic disorders

Epstein-Barr virus

Epstein-Barr virus, negative

evidence-based research

extralimbic encephalitis

eye movement, painful

face, numbness of

facial nerve palsy

facial nerve palsy, bilateral

faciobrachial dystonic seizure

Fisher's syndrome

fluorescein angiography

fungal infection, CNS

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

giant cell arteritis

glioblastoma multiforme(astrocytoma Gr.III)

glutamic acid decarboxylase, antibody

GM1 ganglioside antibodies

granulomatosis with polyangiitis

granulomatous disease

granulomatous hypophysitis

Guillain Barre syndrome

hallucination, olfactory

headache, children

headache, drug induced

headache, episodic

headache, preventive treatment

headache, prophylaxis

headache, recurrent

headache, severe

headache, treatment of

headache, unilateral

hemiplegia, progressive

hemosiderosis of CNS, superficial

hepatic failure

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex virus infection, immunosuppressed patient

highly active antiretroviral therapy

Hodgkin's disease

human immunodeficiency virus type 1

hypereosinophilic syndrome(HES)

hypersensitivity reaction

hypertrophic intracranial pachymeningitis

hypoglycorrhachia

hypothalamus, lesion of

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

IgG4-related disease

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

in situ hybridization

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

intellectual deficit

interferon beta 1-a

interferon beta 1-b

internal carotid artery

intracerebral hemorrhage

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

lactic dehydrogenase(LDH)

leucine rich glioma inactivated 1 antibodies

leukoencephalopathy

leukoencephalopathy, toxic

level of consciousness, decreased

life expectancy

limbic encephalitis

lipoprotein receptor-related protein 4

listeria monocytogenes

lymph node biopsy

lymphadenopathy

lymphadenopathy, hilar

lymphoma involving CNS

lymphoma, primary of CNS

lymphomatoid granulomatosis

mediastinum, lymph-node biopsy

mediastinum, mass of

medication withdrawal

medulla oblongata

medulla oblongata, lesion of

melanoma, malignant

memory, defect of recent

memory, impairment of

meningeal enhancement

meningitis, aseptic

meningitis, bacterial

meningitis, basilar

meningitis, carcinomatous

meningitis, chronic

meningitis, drug induced

meningitis, iatrogenic

meningitis, listeria monocytogenes

meningitis, lymphomatous

meningitis, neutrophilic

meningitis, noninfectious

meningitis, pneumococcal

meningitis, recurrent

meningoencephalitis

meningoencephalopathy

meningomyelitis

mental status, abnormal

mesial temporal lobe

microhemorrhage, intracerebral

microscopic polyangiitis

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebral artery

migraine, children

migraine, chronic

migraine, intractable

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mild cognitive impairment

monoclonal antibodies

monoclonal antibodies for tumor cells in CSF

monoclonal gammopathy

mononeuropathy multiplex

motor neuron disease

movement disorder

MRI, angiography

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, nodular enhancement

MRI, ring sign, open

MRI, spinal cord

MRI, spinal cord, increased intramedullary cord signal

multinucleated giant cell

multiple sclerosis

multiple sclerosis, children

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, etiology of

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, relapsing

multiple sclerosis, treatment of

muscle stiffness

muscle weakness

muscle weakness, proximal

MuSK antibodies

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, drug resistant

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myasthenic syndrome

myelitis, longitudinal

myelitis, transverse

myelitis, transverse, recurrent

natalizumab, discontinuation

nausea and vomiting

necrotizing vasculitis

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-differential diagnosis

neoplasm, primary of CNS-recurrent

neoplasm, primary of CNS-survival

neoplasm, primary of CNS-treatment of

neurexin-3 alpha antibodies

neurofibromatosis 2

neurofilament light chain protein

neurologic complications

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neurolymphomatosis

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuronal cell surface antigen

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, vasculitic, systemic

NMDA antagonists

nonsteroidal anti-inflammatory drug

oculovestibular reflex

old age, neurology of

ophelia syndrome

ophthalmoplegia

opportunistic infection

opportunistic infection, CNS

optic chiasm, lesion of

optic nerve, lesion of

optic neuropathy

optic neuropathy, toxic

oral contraceptives

pain, abdominal

paraneoplastic cerebellar degeneration

parasitic infection

parasitic infection, CNS

paroxysmal nocturnal hemoglobinuria

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

personality change

pituitary stalk

pituitary stalk, enlarged

plasmapheresis, complications of

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

polymerase chain reaction

polymerase chain reaction, false negative

polymyalgia rheumatica

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

pontine hemorrhage

posterior leukoencephalopathy syndrome

postoperative neurologic complications

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protozoan infection

psoriatic arthritis

psychiatric problems in neurologic disorders

psychosis, childhood

ptosis, bilateral

pulmonary infiltrates

quality of life

radiation therapy, CNS treatment and complications with

radiation therapy, total body

rapidly fatal neurologic illness

rapidly progressing neurologic illness

regional enteritis

remote effect of cancer on the nervous system

renal transplantation

respiratory failure

rheumatoid arthritis

rheumatoid arthritis, neurologic complications of

risk stratification

risk-benefit assessment

rozanolixizumab

sarcoidosis, CNS

sedimentation rate

sedimentation rate, elevated

seizure, intractable

seizure, psychomotor-temporal lobe

serologic testing

serologic testing, false negative

serotonin agonist

shared decision making

shoulder, pain in

skin, lesions in neurologic disorders

sleep pathology and physiology

speech disorder

speech disorder, childhood

spinal cord, lesion of

splenic-vein thrombosis

stem cell transplantation

steroid sparing therapy

steroid therapy, CNS treatment and complications with

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

subarachnoid hemorrhage

systemic illness

T cell lymphocytes

temporal lobe, lesion

temporal lobe, lesion, bilateral

teratoma, ovarian

thalamus, lesion of

thalamus, lesion of-bilateral

thrombocytopenia

thymic hyperplasia

tissue plasminogen activator, intravenous

toxoplasmosis, acquired

toxoplasmosis, CNS

TRAILBLAZER-ALZ trial

transient ischemic attack

treatment of neurologic disorder

treatment resistant

trigeminovascular system

tumor necrosis factor

tumor necrosis factor inhibitor

vaccination, neurologic complications with

vagus nerve stimulation

varicella zoster virus

varicella zoster virus, encephalitis

varicella zoster virus, vasculopathy

vascular endothelial growth factor

ventricular assist device

viral infection

viral infection, CNS

vision, blurred

vomiting, intractable

walking, difficulty with

water channel antibodies

weakness, fatiguable

weakness, generalized

white matter disease

white matter disease, subcortical

Showing articles 450 to 500 of 877 << Previous Next >>

Donepezil for the Treatment of Agitation in Alzheimers Disease
NEJM 357:1382-1392,1441, Howard,R.J.,et al, 2007

Treatment Options in the Modern Management of Parkinson Disease
Arch Neurol 64:1083-1088, Schapira,A.H.V., 2007

Discontinuation of Statin Therapy and Clinical and Outcome After Ischemic Stroke
Stroke 38:2652-2657, Colvicchi,F.,et al, 2007

Managing Acute Organophosphorus Pesticide Poisoning
BMJ 334:629-634, Roberts,D.M.&Aaron,C.K., 2007

Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis
JAMA 297:1344-1353,1376, Crouse III,J.R.,et al, 2007

The Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin for the Prevention of Venous Thromboembolism After Acute Ischaemic Stroke (PREVAIL Study): An Open-Label Randomised Comparison
Lancet 369:1347-1355, Sherman,D.G.,et al, 2007

Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007

Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials
Stroke 38:874-880, Akins,P.T.,et al, 2007

Narrative Review: Reversible Cerebral Vasoconstriction Syndromes
Ann Intern Med 146:34-44, Calabrese,L.H.,et al, 2007

Evidence Report: The Medical Treatment of Ocular Myasthenia (An Evidence-Based Review)
Neurol 68:2144-2149, Benatar,M. &Kaminski,H.J., 2007

Galantamine Treatment of Vascular Dementia: A Randomized Trial
Neuorl 69:448-458, Auchus,A.P.,et al, 2007

Donepezil Preserves Cognition and Global Function in Patients With Severe Alzheimer Disease
Neurol 69:459-469, Black,S.E.,et al, 2007

Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study
Stroke 38:1881-1885,1736, Hackam,D.D. &Spence,J.D., 2007

Combining Aspirin With Oral Anticoagulant Therapy: Is This a Safe and Effective Practice in Patients With Atrial Fibrillation?
Stroke 38:1652-1654, Gorelick,P.B., 2007

The Clinical and Radiological Spectrum of Reversible Cerebral Vasoconstriction Syndrome. A Prospective Series of 67 Patients
Brain 130:3091-3101, Ducros, A.,et al, 2007

Primary Episodic Ataxias:Diagnosis, Pathogenesis and Treatment
Brain 130:2484-2493, Jen, J.C.,et al, 2007

Obsessive-Compulsive Disorder
BMJ 333:424-429, Heyman,I.,et al, 2006

High-Dose Atorvastatin After Stroke or Transient Ischemic Attack
NEJM 355:549-559,613, The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators, 2006

Discontinuation of Statin Treatment in Stroke Patients
Stroke 37:2640-2643, Endres,M. &Laufs,U., 2006

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimers Disease
NEJM 355:1525-1538,1604, Schneider,L.S.,et al, 2006

Effect of Donepezil on Motor and Cognitive Function in Huntington Disease
Neurol 67:1268-1271, Cubo,E.,et al, 2006

Behavioral Effects of Memantine in Alzheimer Disease Patients Receiving Donepezil Treatment
Neurol 67:57-63, Cummings,J.L.,et al, 2006

Coxibs and Alzheimers Disease: Should They Stay or Should They Go?
Ann Neurol 59:219-228, Firuzi,O. &Pratico,D., 2006

Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006

Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006

Safety of Rasagiline in Elderly Patients with Parkinson Disease
Neurol 66:1427-1429, Goetz,C.G.,et al, 2006

Hyponatremia in Neurologic Patients: Consequences and Approaches to Treatment
The Neurologist 12:117-126, Diringer,M.N. &Zazulia,A., 2006

Major Congential Malformations After First-Trimester Exposure to ACE Inhibitors
NEJM 354:2443-2451,2498, Cooper,W.O.,et al, 2006

Practice Parameter: Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease (An Evidence-Based Review)
Neurol 66:996-1002, Miyasaki,J.M.,et al, 2006

Donepezil in Patients with Severe Alzheimers Disease: Double-Blind, Parallel-Group, Placebo-Controlled Study
Lancet 367:1057-1065,1031, Winblad,B.,et al, 2006

Statin-Associated Myasthenia Gravis
Medicine 85:82-85, Purvin,V.,et al, 2006

Duloxetine-induced Syndrome of Inappropriate Antidiuretic Hormone Secretion and Seizures
Neurol 66:773-774, Maramatton,B.V., 2006

Two Patients With COMT Inhibitor-Induced Hepatic Dysfunction and UGT1A9 Genetic Polymorphism
Neurol 65:1820-1822, Martignoni,E.,et al, 2005

Terminating Migraine with Allodynia and Ongoing Central Sensitization Using Parenteral Administration of COX1/COX2 Inhibitors
Headache 45:850-861, Jakubowski,M.,et al, 2005

Expanding Indications for Statins in Cerebral Ischemia
Arch Neurol 62:67-72,23, Ovbiagele,B.,et al, 2005

Statins Are Associated With Better Outcomes After Carotid Endarterectomy in Symptomatic Patients
Stroke 36:2072-2076,2058, Kennedy,J.,et al, 2005

Statins and Cognitive Functioning the Elderly
Neurol 65:1388-1394, Bernick,C.,et al, 2005

Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients
Medicine 84:377-385, Melli,G.,et al, 2005

Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease
JNNP 76:1624-1629, Masse,I.,et al, 2005

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
NEJM 352:2379-2388,2439, Petersen,R.C.,et al, 2005

Statin Use and the Risk of Incident Dementia
Arch Neurol 62:1047-1051, Rea,T.D.,et al, 2005

Lipid-Lowering Agent Use at Ischemic Stroke Onset is Associated with Decreased Mortality
Neurol 65:253-258, Elkind,M.S.V.,et al, 2005

Cholinesterase Inhibitors for Patients with Alzheimers Disease: Systematic Review of Randomised Clinical Trials
BMJ 331:321-323, Kaduszkiewicz,H.,et al, 2005

Diagnosis and Initial Management of Parkinsons Disease
NEJM 353:1021-1027, Nutt,J.G.&Wooten,G.F., 2005

Efficacy and Safety of Cholesterol-Lowering Treatment: Prospective Meta-Analysis of Data from 90056 Participants in 14 Randomised Trials of Statins
Lancet 366:1267-1278, Cholesterol Treatment Trialists (CTT) Collaborators, 2005

A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005

The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005

Rasagiline as an Adjunct to Levodopa in Patients With Parkinsons Disease and Motor Fluctuations (LARGO, Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily, Study)
Lancet 365:947-954, 914, Rascol,O., et al, 2005

Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005

Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005

Showing articles 450 to 500 of 877 << Previous Next >>